ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc.

NEW YORK, Oct. 23, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Lumos Pharma, Inc. (NASDAQ: LUMO) and its board of directors concerning the proposed acquisition of the company by Double Point Ventures LLC. Stockholders will receive $4.25 and one contingent value right for each share of Lumos Pharma stock that they hold. The transaction is expected to close by the end of 2024.